Publications by authors named "Luke I Jones"

Article Synopsis
  • Cystic fibrosis (CF) is a genetic disorder caused by mutations in the CFTR gene, affecting mucus function in the lungs and leading to chronic infections and inflammation.
  • Recent advances in highly effective CFTR modulator therapy (HEMT) have improved the health and longevity of people with CF, although issues with persistent pathogen colonization remain.
  • This review aims to explore the impact of HEMT on CF lung microbiome and highlight gaps in research since the treatment is relatively new.
View Article and Find Full Text PDF

The number of adults living with cystic fibrosis (CF) has already increased significantly because of drastic improvements in life expectancy attributable to advances in treatment, including the development of highly effective modulator therapy. Chronic airway inflammation in CF contributes to morbidity and mortality, and aging processes like inflammaging and cell senescence influence CF pathology. Our results show that single-cell RNA sequencing data, human primary bronchial epithelial cells from non-CF and CF donors, a CF bronchial epithelial cell line, and Cftr-knockout (Cftr-/-) rats all demonstrated increased cell senescence markers in the CF bronchial epithelium.

View Article and Find Full Text PDF

Rationale: The role of MUC5B mucin expression in IPF pathogenesis is unknown. Bleomycin-exposed rodent models do not exhibit sustained fibrosis or airway remodeling. Unlike mice, ferrets have human-like distribution of MUC5B expressing cell types and natively express the risk-conferring variant that induces high MUC5B expression in humans.

View Article and Find Full Text PDF
Article Synopsis
  • Idiopathic pulmonary fibrosis (IPF) is a serious lung disease marked by excessive collagen buildup, leading to respiratory failure, with no existing treatments to effectively reverse fibrosis despite some therapies that slow progression.* -
  • The study used single-cell RNA sequencing and various models to investigate the role of O-linked N-Acetylglucosamine (O-GlcNAc) transferase (OGT) in regulating collagen production and fibrosis in IPF, finding it elevated in IPF patients and crucial in modulating Smad3 activation.* -
  • Results suggest that inhibiting OGT can reduce collagen accumulation in IPF, making it a promising target for therapies aimed at both fibrosis resolution and other related diseases characterized by excessive extracellular
View Article and Find Full Text PDF